Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Zenas Biopharma Inc.
Swot
Zenas Biopharma Inc. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Zenas Biopharma Inc. has 18 Strengths, 5 Weaknesses, 3 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(18)
Weakness
(5)
Opportunity
(3)
Threats
(1)
Others
(0)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over the Quarter (3 Months)
Stocks whose current price is 20% higher than week low, and more than previous close
PEG lower than Industry PEG
New 52 week high today
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Companies with Low Debt
Increasing Revenue every quarter for the past 2 quarters
Stock gained more than 20% in one month
Top Gainers
Stock with Low PE (PE < = 10)
RSI indicating price strength
Stocks near 52 Week High with Significant Volumes
Volume Shockers
Biggest Price Gainers from Open
Stocks Outperforming their Industry Price Change in the Quarter
Stocks with Quarter Change % less than Industry
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Lowest Momentum Scores (Technical Scores)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low Piotroski Score : Companies with weak financials
Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
Stocks rising sharply on very low month volumes
